CBMG Financials 07/16/2014 01:00:42
Cellular Biomedicine Group, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 4,070 274 286 1,742
Cost of Revenue - - - -
Gross Profit 4,070 274 286 1,742
Operating Expenses
Research and Development 1,891 3,214 - -
Sales, General and Admin. 11,047 4,121 1,322 1,431
Non-Recurring Items 4,259 - - -
Other - - - -
Operating Income (13,127) (7,062) (1,037) 311
Income From Continuing Operations
Add'l Income/Expense Items (68) 30 530 -
Earnings Before Interest and Tax (13,195) (7,032) (507) 311
Interest Expense 258 - 10 486
Earnings Before Tax (13,453) (7,032) (516) (175)
Income Tax 344 - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (13,797) (7,032) (464) (175)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (13,797) (7,032) (516) (175)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (13,797) (7,032) (516) (175)